GDP Compliance
Active substances and medicinal products shall be distributed in accordance with good distribution practices. Member States shall enter the certificates of good distribution practices which they issue in the Union database (EudraGMDP) in accordance with Art. 111(6) of the Directive 2001/83/EC as amended. |
The Community formats for the GDP Certificate for Medical Products and for active substances are published in the Compilation of Community Procedures, which can be found at the following location: Click Here for Download /Open in pdf |
Compilation of Community Procedures on Inspections and Exchange of Information |
Introduction
The Compilation of Community Procedures on Inspections and Exchange of Information, formerly
known as the Compilation of Community Procedures on Administrative Collaboration and
Harmonisation of Inspections, is a tool for facilitating co-operation between the GMP inspectorates
of the Member States and a means of achieving harmonisation.
The procedures within it provide
the basis for national procedures that form part of the national GMP inspectorates’ quality systems.
These quality systems are based on a framework laid down in one of the documents of the
Compilation. In July 2010 documents connected with Good Distribution Practice (GDP) inspections
started to be added to the Compilation.
The contents of the Compilation of Procedures are constantly updated developed and agreed, under
the co-ordination of the European Medicines Agency, by representatives of the GMP Inspectorates
of each member state, including those supervising the manufacture and import of veterinary
medicinal products only.
Once agreed, they are adopted by the European Commission and then
published on its behalf by the European Medicines Agency.
The Heads of Medicines Agencies have agreed to the setting up of a joint audit programme of GMP
inspectorates to maintain mutual confidence in the GMP inspection systems of each member state
by the other member states, and the Compilation provides criteria on which the audits are based.
Member states are obliged to take account of the Compilation of Procedures by virtue of Art. 3(1)
of Directive 2003/94/EC. Until such time as the corresponding GMP directive for veterinary
medicinal products, Directive 91/412/EEC, is amended accordingly, GMP Inspectorates dealing
exclusively with veterinary medicinal products have voluntarily agreed to abide by it, although it is
recognised that the formats for inspection reports, manufacturing authorisations and GMP
certificates are of a binding nature by virtue of Art. 51 of Directive 2001/82/EC, as amended.
Quality Systems Framework for GMP Inspectorates
Table of contents:
• Introduction
• Purpose
• Scope
• Definitions
• Quality Manual
• Administrative Structure
• Organisation and Management
• Documentation and Change Control
• Records
• Inspection Procedures
• Inspection Resources
• Internal Audit
• Quality Improvement and
Corrective/Preventive Action
• Complaints
• Issue and Withdrawal of Licenses and
GMP Certificates
• Handling Suspected Quality Defects
and Rapid Alert System
• Liaison with OMCL
• Sub-Contracting and Assessing
• Publications
Source: EudraGMP
0 comments:
Post a Comment